Skip to main content
Fig. 3 | Renal Replacement Therapy

Fig. 3

From: Investigation for the efficacy of COVID-19 vaccine in Japanese CKD patients treated with hemodialysis

Fig. 3

Neutralizing antibody 3 months after the second vaccination. The neutralizing antibody titers showed a strong positive correlation with anti-S1 antibody titer both in HD group and in Control group (HD: r = 0.81, p < 0.0001, Control: r = 0.40, p < 0.0001) (a, b). Also, HD group had lower neutralizing antibody titers at 3 months after the second vaccination (HD: 55.6 AU/mL vs Control: 76.7 AU/mL, p < 0.0014) (c). **p < 0.01. HD, hemodialysis; AU, antibody unit; BAU, binding antibody unit

Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us